Related Experiment Video

Updated: Jun 7, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Antithrombotic treatment in acute coronary syndromes

S P Hoole1, J Saw

  • 1Vancouver General Hospital, University of British Columbia, BC, Canada.

Minerva Medica
|October 30, 2010
PubMed

Insights

This review discusses antithrombotic agents for acute coronary syndrome (ACS) management. It highlights current therapies and next-generation combinations balancing anti-ischemic efficacy with reduced bleeding risk.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Platelet activation and thrombin generation are key in acute coronary syndrome (ACS) pathophysiology.
  • Current treatments target platelet aggregation and thrombin to maintain coronary artery patency.
  • The field is advancing towards novel antithrombotic strategies.

Purpose of the Study:

  • To review the contemporary management of ACS patients using antithrombotic agents.
  • To discuss the evolving landscape of antithrombotic therapies in ACS.
  • To explore next-generation antithrombotic combinations.

Main Methods:

  • Literature review of antithrombotic agents in ACS.
  • Analysis of current pharmacotherapies and their mechanisms.
  • Evaluation of emerging antithrombotic combinations.

Main Results:

  • Current therapies effectively inhibit platelet aggregation and thrombin formation.
  • Next-generation agents aim to optimize the balance between anti-ischemic and bleeding risks.
  • The development of novel antithrombotic combinations is ongoing.

Conclusions:

  • Antithrombotic therapy is crucial for managing ACS.
  • Optimizing efficacy while minimizing bleeding remains a primary goal.
  • Continued research into novel antithrombotic agents is essential for improving patient outcomes.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...